Pulse Biosciences Inc (PLSE)

04:06 AM

Pulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation Story - Yahoo Finance

04:06 AM

Apr 20, 2026

Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Investing News Network

Apr 20, 2026

Apr 20, 2026

Pulse Biosciences (PLSE) to Showcase Innovations at Heart Rhythm Society 2026 Meeting - GuruFocus

Apr 20, 2026

Apr 20, 2026

Pulse Biosciences Starts US Trial for Cardiac Catheter System - HarianBasis.co

Apr 20, 2026

Apr 20, 2026

Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial - Insider Monkey

Apr 20, 2026

Apr 20, 2026

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Business Wire

Apr 20, 2026

Apr 19, 2026

Total debt per share of Pulse Biosciences, Inc. – FWB:6L8 - TradingView

Apr 19, 2026

Apr 18, 2026

Pulse (PLSE) Stock: Is It Moving in a Trend (Breakout Watch) 2026-04-18Asset Allocation - Xã Vĩnh Công

Apr 18, 2026

Apr 17, 2026

Pulse Biosciences (NASDAQ:PLSE) Trading 10.1% HigherHere's Why - MarketBeat

Apr 17, 2026

Apr 17, 2026

Pulse Biosciences to Host Analyst Event on April 25, 2026 - The Joplin Globe

Apr 17, 2026

Apr 17, 2026

PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill

Apr 17, 2026

Apr 16, 2026

Pulse Biosciences Targets Thyroid Nodules With New Device Study, Eyeing a Minimally Invasive Niche - TipRanks

Apr 16, 2026

Apr 16, 2026

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy - TipRanks

Apr 16, 2026

Apr 16, 2026

Pulse Biosciences posts updated investor deck with pivotal nsPFA cardiac study details - TradingView

Apr 16, 2026

Apr 16, 2026

Pulse Biosciences (PLSE) updates investor deck with 2026 clinical goals - Stock Titan

Apr 16, 2026

Apr 15, 2026

Trading Systems Reacting to (PLSE) Volatility - Stock Traders Daily

Apr 15, 2026

Apr 13, 2026

Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛

Apr 13, 2026

Apr 13, 2026

Income Plays: Does Pulse Biosciences Inc have strong fundamentalsPortfolio Update Summary & Reliable Price Breakout Signals - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - Yahoo Finance

Apr 13, 2026

Apr 13, 2026

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story? - Sahm

Apr 13, 2026

Apr 12, 2026

Pulse Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 12, 2026

Apr 12, 2026

Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy? - Yahoo Finance

Apr 12, 2026

Apr 11, 2026

Q4 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus

Apr 11, 2026

Apr 10, 2026

Pulse Biosciences hires Liane Teplitsky as COO - MedTech Dive

Apr 10, 2026

Apr 09, 2026

Pulse Biosciences names Liane Teplitsky as chief operating officer By Investing.com - Investing.com Australia

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences, Inc. (PLSE) stock price, news, quote and history - Yahoo Finance Singapore

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences Strengthens Executive Leadership Team - Investing News Network

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences appoints new COO to advance commercialization - TipRanks

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences Appoints Liane Teplitsky as Chief Operating Officer Effective April 8, 2026 - Minichart

Apr 09, 2026

Apr 09, 2026

Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences - TradingView

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences (PLSE) hires new COO with large inducement equity grants - Stock Titan

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences Names Liane Teplitsky Chief Operating Officer - marketscreener.com

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences strengthens executive leadership team - marketscreener.com

Apr 09, 2026

Apr 09, 2026

Pulse Biosciences names Liane Teplitsky as chief operating officer - Investing.com

Apr 09, 2026

Apr 08, 2026

Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now - Seeking Alpha

Apr 08, 2026

Apr 08, 2026

How Low Can PLSE Really Go In A Market Crash? - Trefis

Apr 08, 2026

Apr 08, 2026

Pulse Biosciences Stock Drops 13% In A Day, Why You Shouldn Not Be Buying The Stock - Trefis

Apr 08, 2026

Apr 07, 2026

Pulse Biosciences Inc Enrolls First Patients in NANOPULSE-AF Ide Pivotal Clinical Study Evaluating nsPFA Cardiac Catheter System for Atrial Fibrillation - marketscreener.com

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences Enrolls 1st Patient in nPulse PFA Tech Trial for AFib - Medical Product Outsourcing

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences Inc (PLSE) Shares Gap Down to $19.14 on Apr 7 - GuruFocus

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences begins pivotal atrial fibrillation trial By Investing.com - Investing.com South Africa

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study - TipRanks

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences, Inc. Files 8-K with SEC Detailing Company Information and Nasdaq Listing - Minichart

Apr 07, 2026

Apr 07, 2026

First patients treated in Pulse Biosciences (NASDAQ: PLSE) NANOPULSE-AF AFib trial - Stock Titan

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences begins pivotal atrial fibrillation trial - Investing.com

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences (NASDAQ: PLSE) recently announced that its pivotal clinical study of the Npulse™ Cardiac Catheter System for atrial fibrillation treatment (Nanopulse-Af Ide) has completed enrollment of the first group of patients. - Bitget

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences enrolls first patients in Nanopulse-AF IDE pivotal clinical study evaluating nPulse(TM) cardiac catheter system for atrial fibrillation - marketscreener.com

Apr 07, 2026

Apr 07, 2026

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation - TradingView — Track All Markets

Apr 07, 2026

Apr 06, 2026

PLSE SEC FilingsPulse Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 06, 2026